Perioperative Pharmacological Management of Pulmonary Hypertensive Crisis during Congenital Heart Surgery
Authors:
Open Access
- 1 March 2014
- journal article
- review article
- Published by Wiley in Pulmonary Circulation
- Vol. 4 (1) , 10-24
Abstract
Pulmonary hypertensive crisis is an important cause of morbidity and mortality in patients with pulmonary arterial hypertension secondary to congenital heart disease (PAH-CHD) who require cardiac surgery. At present, prevention and management of perioperative pulmonary hypertensive crisis is aimed at optimizing cardiopulmonary interactions by targeting prostacyclin, endothelin, and nitric oxide signaling pathways within the pulmonary circulation with various pharmacological agents. This review is aimed at familiarizing the practitioner with the current pharmacological treatment for dealing with perioperative pulmonary hypertensive crisis in PAH-CHD patients. Given the life-threatening complications associated with pulmonary hypertensive crisis, proper perioperative planning can help anticipate cardiopulmonary complications and optimize surgical outcomes in this patient population.Keywords
Funding Information
- National Natural Science Foundation of China (30900622, 81070159)
This publication has 131 references indexed in Scilit:
- Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial HypertensionCardiovascular Therapeutics, 2013
- Initial Experience With Tadalafil in Pediatric Pulmonary Arterial HypertensionPediatric Cardiology, 2012
- Advances in pediatric pulmonary arterial hypertensionCurrent Opinion in Cardiology, 2012
- Efficacy and Safety of Bosentan in Adults with Simple and Complex Eisenmenger's SyndromeCongenital Heart Disease, 2011
- Advanced therapy for pulmonary arterial hypertension due to congenital heart disease: a clinical perspective in a new therapeutic eraNetherlands Heart Journal, 2011
- Influence of PEI as a core modifying agent on PLGA microspheres of PGE1, a pulmonary selective vasodilatorInternational Journal of Pharmaceutics, 2011
- Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart diseaseIntensive Care Medicine, 2010
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- Treatment of pediatric pulmonary hypertensionVascular Health and Risk Management, 2009
- Effects of Long-Term Sildenafil Treatment for Pulmonary Hypertension in Infants with Chronic Lung DiseaseThe Journal of Pediatrics, 2009